Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Volumn 122, Issue 8, 2014, Pages 469-476

  Li, C J ^a   Yu, Q ^a   Yu, P ^a   Zhang, Q M ^a   Ding, M ^a   Liu, X J ^a   Yu, D M ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; ANTIDIABETIC AGENT; DIPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE BLOOD LEVEL; INSULIN; LIRAGLUTIDE; METFORMIN; NITRILE; PYRROLIDINE DERIVATIVE; SAXAGLIPTIN; VILDAGLIPTIN;

ADULT; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY WEIGHT; CHINA; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DRUG COMBINATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADAMANTANE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY WEIGHT; CHINA; DIABETES MELLITUS, TYPE 2; DIPEPTIDES; DRUG THERAPY, COMBINATION; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; NITRILES; PYRROLIDINES; TREATMENT OUTCOME;

EID: 84930278561     PISSN: None     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1374586     Document Type: Article

References (0)